Blue Jet Healthcare Intrinsic Value
Blue Jet Healthcare intrinsic value. Blue Jet Healthcare (BLUEJET) median intrinsic value is ₹680.00 from 3 valuation models (range ₹159–₹1192), vs current price ₹531.50 — +27.9% upside (Trading Below Calculated Value), margin of safety 21.8%. Compare with BLUEJET fundamental valuation to assess whether the stock is under or overvalued.
BLUEJET Valuation Methods Summary — DCF, Graham Number & P/E
Blue Jet Healthcare intrinsic value across 3 models vs current price ₹531.50 — upside/downside and value range per method. For current market price and key ratios, visit BLUEJET share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹680.00 | ₹612.00 - ₹748.00 | +27.9% | Book Value/Share: ₹340.00, P/B: 2.0x |
| Simple DCF (5Y) | dcf | ₹1191.92 | ₹953.54 - ₹1430.30 | +124.3% | CF Growth: 4.9%, Discount: 15% |
| Dividend Yield Method | dividend | ₹159.45 | ₹143.50 - ₹175.40 | -70.0% | DPS: ₹1.20, Target Yield: 2.5% |
BLUEJET Intrinsic Value vs Market Price — All Valuation Models
Blue Jet Healthcare fair value range ₹159–₹1192 vs current market price ₹531.50 across 3 valuation models. Read Blue Jet Healthcare dividend payments for the complete payout history and dividend yield track record.
BLUEJET Intrinsic Value Analysis — Undervalued or Overvalued?
Blue Jet Healthcare median intrinsic value ₹680.00, current price ₹531.50 — Trading Below Calculated Value by 27.9%, margin of safety 21.8%.
What is the intrinsic value of BLUEJET?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Blue Jet Healthcare (BLUEJET) is ₹680.00 (median value). With the current market price of ₹531.50, this represents a +27.9% variance from our estimated fair value.
The valuation range spans from ₹159.45 to ₹1191.92, indicating ₹159.45 - ₹1191.92.
Is BLUEJET undervalued or overvalued?
Based on our multi-method analysis, Blue Jet Healthcare (BLUEJET) appears to be trading below calculated value by approximately 27.9%.
BLUEJET Financial Health — Key Ratios vs Industry Benchmarks
Blue Jet Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 11.82 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
BLUEJET Cash Flow Quality — Operating & Free Cash Flow
Blue Jet Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2021 | ₹129 Cr | ₹104 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹123 Cr | ₹101 Cr | Positive Free Cash Flow | 8/10 |